Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Feb;89(2):206–213. doi: 10.1111/j.1349-7006.1998.tb00550.x

Oral Administration of a Kampo (Japanese Herbal) Medicine Juzen‐taiho‐to Inhibits Liver Metastasis of Colon 26‐L5 Carcinoma Cells

Yasuharu Ohnishi 1,2, Hideki Fujii 1, Yoshihiro Hayakawa 1, Rieko Sakukawa 1, Takeshi Yamaura 1, Takashi Sakamoto 2, Kazuhiro Tsukada 2, Masao Fujimaki 2, Shinyu Nunome 3, Yasuhiro Komatsu 3, Ikuo Saiki 1,✉
PMCID: PMC5921762  PMID: 9548449

Abstract

We have investigated the inhibitory effect of oral administration of Juzen‐taiho‐to, a Kampo Japanese herbal medicine, on liver metastasis by the inoculation of a liver‐metastatic variant (L5) of murine colon 26 carcinoma cells into the portal vein. Oral administration of Juzen‐taiho‐to for 7 days before tumor inoculation resulted in dose‐dependent inhibition of liver tumor colonies and significant enhancement of survival rate as compared with the untreated control, without side effects. We also found that liver metastasis of L5 cells was enhanced in BALB/c mice pretreated with anti‐asialo GM1 serum or 2‐chloroadenosine, and in BALB/c nu/nu mice, compared to normal mice. This indicates that NK cells, macrophages, and T‐cells play important roles in the prevention of metastasis of tumor cells. Juzen‐taiho‐to significantly inhibited the experimental liver metastasis of colon 26‐L5 cells in mice pretreated with anti‐asialo GM1 serum and untreated normal mice, whereas it did not inhibit metastasis in 2‐chloroadenosine‐pretreated mice or T‐cell‐deficient nude mice. Oral administration of Juzen‐taiho‐to activated peritoneal exudate macrophages (PEM) to become cytostatic against the tumor cells. These results show that oral administration of Juzen‐taiho‐to inhibited liver metastasis of colon 26‐L5 cells, possibly through a mechanism mediated by the activation of macrophages and/or T‐cells in the host immune system. Thus, Juzen‐taiho‐to may be efficacious for the prevention of cancer metastasis.

Keywords: Juzen‐taiho‐to, Liver metastasis, Colon 26‐L5, Macrophage

Full Text

The Full Text of this article is available as a PDF (312.6 KB).

REFERENCES

  • 1. ) Eisenberg , B. , DeCosse , J. J. , Harford , F. and Michalek , J.Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients . Cancer (Phila.) , 49 , 1131 – 1134 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Galandivk , S. , Wieand , H. S. , Moertel , C. G. , Cha , S. S. , Fitzgibbons , R. J. , Jr. , Premberton , J. H. and Wolff , B. G.Patterns of recurrence after curative resection of carcinoma of the colon and rectum . Surg. Gynecol. Obstet. , 174 , 27 – 32 ( 1992. ). [PubMed] [Google Scholar]
  • 3. ) Gastrointestinal Tumor Study Group . Prolongation of the disease‐free interval in surgically resected rectal cancer . N. Engl. J. Med. , 312 , 1465 – 1472 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Bengmark , S. and Hafstrom , L.The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma verified by laparotomy . Cancer , 23 , 198 – 202 ( 1969. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Gavowski , T. J. , Iwatsuki , S. , Madariaga , J. R. , Selby , R. , Todo , S. , Irish , W. and Startzl , T. S.Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors . Surgery , 116 , 703 – 711 ( 1994. ). [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Corbett , T. H. , Griswold , D. P. , Jr , Roberts , B. J. , Peckham , J. C. and Schabel , F. M. , Jr . Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure . Cancer Res. , 35 , 2434 – 2439 ( 1975. ). [PubMed] [Google Scholar]
  • 7. ) Ohnishi , Y. , Sakamoto , T. , Fujii , H. , Kimura , F. , Murata , J. , Tazawa , K. , Fujimaki , M. , Sato , Y. , Kondo , M. , Une , Y. , Uchino , J. and Saiki , I.Characterization of a liver metastatic variant of murine colon 26 carcinoma cells . Tumor Biol. , 18 , 113 – 122 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Ohnishi , Y. , Fujii , H. , Murakami , K. , Sakamoto , T. , Tsukada , K. , Fujimaki , M. , Kojima , M. and Saiki , I.A new pseudopeptide analogue of Arg‐Gly‐Asp (RGD) sequence inhibits liver metastasis of colon 26‐L5 carcinoma cells . Cancer Lett. ( 1998. ), in press . [DOI] [PubMed]
  • 9. ) Maruyama , H. , Kawamura , H. , Takemoto , N. , Komatsu , Y. , Aburada , M. and Hosoya , E.Effect of Juzentaihoto on phagocytes . Jpn. J. Inflammation , 8 , 461 – 465 ( 1988. ) ( in Japanese ). [Google Scholar]
  • 10. ) Haranaka , K. , Satomi , N. , Sakurai , A. , Haranaka , R. , Okada , N. and Kobayashi , M.Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs . Cancer Immunol. Immunother. , 20 , 1 – 5 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. ) Kubota , A. , Okamura , S. , Shimoda , K. , Harada , N. , Omori , F. and Niho , Y.A traditional Chinese herbal medicine, Juzen‐taiho‐to, augments the production of granulocyte/macrophage colony‐stimulating factor from human peripheral blood mononuculear cells in vitro . Int. J. Immunother. , 8 , 191 – 195 ( 1992. ). [Google Scholar]
  • 12. ) Hamada , M. , Fujii , Y. , Yamamoto , H. , Miyazawa , Y. , Shui , S. M. , Tung , Y. C. and Yamaguchi , N.Effect of a kampo medicine, zyuzentaihoto, on the immune reactivity of tumor‐bearing mice . J. Ethnopharmacol. , 24 , 311 – 320 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Kiyohara , H. , Takemoto , N. , Komatsu , Y. , Kawamura , H. , Hosoya , E. and Yamada , H.Characterization of mitogenic oeptic polysaccharides from kampo (Japanese herbal) medicine “Juzen‐Taiho‐To.” Planta Med. , 57 , 254 – 259 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Maruyama , H. , Takemoto , N. , Maruyama , N. , Komatsu , Y. and Kawamura , H.Antitumour effect of Juzentaiho‐to, a Kampo medicine, combined with surgical excision of transplanted Meth‐A fibrosarcoma . Int. J. Immunother. , 9 , 117 – 125 ( 1993. ). [Google Scholar]
  • 15. ) Haranaka , R. , Hasegawa , R. , Nakagawa , S. , Sakurai , A. , Satomi , N. and Haranaka , K.Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC . J. Biol. Response Mod. , 7 , 77 – 90 ( 1988. ). [PubMed] [Google Scholar]
  • 16. ) Sugiyama , K. , Ueda , H. , Ichio , Y. and Yokota , M.Improvement of cisplatin toxicity and lethality by Juzen‐taiho‐to in mice . Biol. Pharm. Bull. , 18 , 53 – 58 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Sugiyama , K. , Ueda , H. and Ichio , Y.Protective effect of Juzen‐taiho‐to against Carboplatin‐induced toxic side effecs in mice . Biol. Pharm. Bull. , 18 , 544 – 548 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Kawamura , H. , Maruyama , H. , Takemoto , N. , Komatsu , Y. , Aburada , M. , Ikehara , S. and Hosoya , E.Accelerating effect of Japanese kampo medicine on recovery of murine haematopoietic stem cells after administration of mitomycin C . Int. J. Immunother. , 5 , 35 – 42 ( 1989. ). [Google Scholar]
  • 19. ) Ohnishi , Y. , Yasuzumi , R. , Fan , H. , Liu , L. , Takao‐Liu , F. , Komatsu , Y. , Hosoya , E. , Good , R. A. and Ikehara , S.Effects of Juzen‐taiho‐toh (TJ‐48), a traditional oriental medicine, on hematopoietic recovery from radiation injury in mice . Exp. Hematol. , 18 , 18 – 22 ( 1990. ). [PubMed] [Google Scholar]
  • 20. ) Ohnishi , Y. , Fujii , H. , Kimura , F. , Mishima , T. , Murata , J. , Tazawa , K. , Fujimaki , M. , Okada , F. , Hosokawa , M. and Saiki , I.Inhibitory effect of a traditional Chinese medicine, Juzen‐taiho‐to, on progressive growth of weakly malignant clone cells derived from murine fibrosarcoma . Jpn. J. Cancer Res. , 87 , 1039 – 1044 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. ) Fidler , I. J.Selection of successive tumor lines for metastasis . Nature (New Biol.) , 242 , 148 – 149 ( 1973. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Komazawa , H. , Saiki , I. , Aoki , M. , Kitaguchi , H. , Satoh , H. , Kojima , M. , Ono , M. , Itoh , I. and Azuma , I.Synthetic Arg‐Gly‐Asp‐Ser analogues of the cell recognition site of fibronectin that retain antimetastatic and anti‐cell adhesive properties . Biol. Pharm. Bull. , 16 , 997 – 1003 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Saiki , I. , Matsumoto , Y. , Murata , J. , Makabe , T. , Yoneda , J. , Okuyama , H. , Kimizuka , F. , Ishizaki , Y. , Kato , I. and Azuma , I.Recombinant fusion polypeptide with cell‐ and heparin‐binding domains of fibronectin inhibits liver metastasis of L5178Y‐ML25 lymphoma cells . Jpn. J. Cancer Res. , 82 , 1120 – 1129 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Fidler , I. J.Macrophages and metastasis — A biological approach to cancer therapy: presidental address . Cancer Res. , 45 , 4714 – 4726 ( 1985. ). [PubMed] [Google Scholar]
  • 25. ) Hanna , N.Role of natural killer cells and control of cancer metastasis . Cancer Metast. Rev. , 1 , 45 – 65 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Habu , S. , Fukui , H. , Shimamura , K. , Kasai , M. , Nagai , Y. , Okumura , K. and Tamaoki , N.In vivo effects of anti‐asialo GM1 . J. Immunol. , 127 , 34 – 38 ( 1981. ). [PubMed] [Google Scholar]
  • 27. ) Saiki , I. , Murata , J. , Iida , J. , Sakurai , T. , Nishi , N. , Matsuno , K. and Azuma , I.Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg‐Gly‐Asp (RGD) and Tyr‐Ile‐Gly‐Ser‐Arg (YIGSR) sequences . Br. J. Cancer , 60 , 722 – 728 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Saito , T. and Yamaguchi , J.2‐Chloroadenosine: a selective lethal effect to mouse macrophages and its mechanism . J. Immunol. , 134 , 1815 – 1822 ( 1981. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES